Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus.

Between 1997 and 2000, 4 human immunodeficiency virus-negative patients in our institution had cryptococcal meningitis with uncontrollable intracranial hypertension. All 4 patients were treated with antifungal drugs as well as ventriculoperitoneal (VP) shunts for intracranial hypertension. Neurological deficits that were unresponsive to pharmacologic treatment were resolved by use of the VP shunt. Uncontrollable elevation of intracranial pressure associated with cryptococcal meningitis can be resolved by use of a VP shunt, even when imaging studies do not reveal hydrocephalus.

[1]  D. Denning,et al.  Cryptococcal meningitis in the immunocompromised host: intracranial hypertension and other complications , 2004, Mycopathologia.

[2]  J. Perfect,et al.  Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Saag,et al.  Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis , 2000 .

[4]  B. Walters,et al.  Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis. , 1999, Diagnostic microbiology and infectious disease.

[5]  D. Hospenthal,et al.  Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  F. Diaz,et al.  Management of elevated intracranial pressure in patients with Cryptococcal meningitis. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[7]  M. C. Bach,et al.  Use of cerebrospinal fluid shunts in patients having acquired immunodeficiency syndrome with cryptococcal meningitis and uncontrollable intracranial hypertension. , 1997, Neurosurgery.

[8]  D. Warrell,et al.  Visual loss in immunocompetent patients with Cryptococcus neoformans var. gattii meningitis. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  A. Casadevall,et al.  Polysaccharide antigen in brain tissue of AIDS patients with cryptococcal meningitis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Giaquinto,et al.  Intracranial hypertension and cryptococcal meningitis in a girl with AIDS , 1996, Brain and Development.

[11]  A. Casadevall,et al.  Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. , 1996, The American journal of pathology.

[12]  E. Corbett,et al.  Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. , 1992, The Journal of infection.

[13]  D. Denning,et al.  Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. , 1991, The American journal of medicine.

[14]  L. M. Tang,et al.  Ventriculoperitoneal shunt in cryptococcal meningitis with hydrocephalus. , 1990, Surgical neurology.

[15]  K. Chan,et al.  Neurosurgical aspects of cerebral cryptococcosis. , 1989, Neurosurgery.

[16]  P. Richardson,et al.  Cerebral cryptococcosis in Malaysia. , 1976, Journal of neurology, neurosurgery, and psychiatry.